Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.08
- Piotroski Score 7.00
- Grade Hold
- Symbol (AEM)
- Company Agnico Eagle Mines Limited
- Price $79.99
- Changes Percentage (4.21%)
- Change $3.23
- Day Low $78.51
- Day High $80.53
- Year High $89.00
Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Mexico, and Finland. It operates through Northern Business and Southern Business segments. The company primarily produces and sells gold deposits, as well as explores for silver, zinc, and copper deposits. Its flagship property is the LaRonde mine located in the Abitibi region of northwestern Quebec, Canada. As of December 31, 2021, the company's LaRonde mine had proven and probable mineral reserves of approximately 3.0 million ounces of gold. It is also involved in exploration activities in Europe, Latin America, and the United States. The company was incorporated in 1953 and is headquartered in Toronto, Canada.
- Last Earnings 02/15/2024
- Ex-Dividend for 5/16 Dividend 11/29/2024
- Dividend Payable 12/16/2024
- Today N/A
- Next Earnings (Estimated) 02/13/2025
- Fiscal Year End N/A
- Average Stock Price Target $80.00
- High Stock Price Target $95.00
- Low Stock Price Target $66.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.79
- Trailing P/E Ratio 80.76
- Forward P/E Ratio 80.76
- P/E Growth 80.76
- Net Income $1.94 B
Income Statement
Quarterly
Annual
Latest News of AEM
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Health Canada approves GSK's Ojjaara for myelofibrosis in anaemia patients
Health Canada has approved GlaxoSmithKline's Ojjaara (momelotinib) for treating myelofibrosis in adults with moderate-to-severe anaemia, based on positive results from Phase III trials....
By Yahoo! Finance | 5 days ago -
Why JW Marriott Dongdaemun Square Seoul Is A Smart Choice For Your First Trip To South Korea's Capital
JW Marriott Dongdaemun Square Seoul, celebrating its tenth anniversary, is an ideal choice for first-time visitors to Seoul....
By Forbes | 1 week ago -
Agnico Eagle Mines Ltd (AEM) Q3 2024 Earnings Call Highlights: Record Financial Performance and ...
Natasha Vaz focuses on optimizing Macassa mill infrastructure for increased throughput. Labor inflation at Agnico is at 3%, split with two-thirds employees and one-third contractors. Hope Bay's Patch ...
By Yahoo! Finance | 2 weeks ago
